volume 61 issue 15 pages 6401-6420

Lipophilic Efficiency as an Important Metric in Drug Design

Ted W Johnson 1
Rebecca A Gallego 1
Martin P Edwards 1
1
 
Oncology Medicinal Chemistry, Pfizer Inc., 10770 Science Center Drive, La Jolla, California 92121, United States
Publication typeJournal Article
Publication date2018-03-28
scimago Q1
wos Q1
SJR1.801
CiteScore11.5
Impact factor6.8
ISSN00222623, 15204804
Drug Discovery
Molecular Medicine
Abstract
Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chemistry lead optimization programs. In this Perspective, using literature drug discovery examples, we discuss the concept of rigorously applying LipE to guide medicinal chemistry lead optimization toward drug candidates with potential for superior in vivo efficacy and safety, especially when guided by physiochemical property-based optimization (PPBO). Also highlighted are examples of small structural modifications such as addition of single atoms, small functional groups, and cyclization that produce large increases in LipE. Understanding the factors that may contribute to LipE changes through analysis of ligand-protein crystal structures and using structure-based drug design (SBDD) to increase LipE by design is also discussed. Herein we advocate for use of LipE analysis coupled with PPBO and SBDD as an efficient mechanism for drug design.
Found 
Found 

Top-30

Journals

10
20
30
40
50
60
70
80
90
Journal of Medicinal Chemistry
82 publications, 27.89%
European Journal of Medicinal Chemistry
16 publications, 5.44%
ACS Medicinal Chemistry Letters
14 publications, 4.76%
Bioorganic and Medicinal Chemistry Letters
10 publications, 3.4%
Bioorganic and Medicinal Chemistry
10 publications, 3.4%
Molecules
9 publications, 3.06%
Journal of Chemical Information and Modeling
6 publications, 2.04%
Angewandte Chemie
6 publications, 2.04%
Angewandte Chemie - International Edition
6 publications, 2.04%
RSC Medicinal Chemistry
6 publications, 2.04%
ChemMedChem
5 publications, 1.7%
International Journal of Molecular Sciences
4 publications, 1.36%
Pharmacological Research
4 publications, 1.36%
Chemistry - A European Journal
4 publications, 1.36%
Journal of the American Chemical Society
4 publications, 1.36%
Bioorganic Chemistry
3 publications, 1.02%
Chemical Science
3 publications, 1.02%
Dalton Transactions
3 publications, 1.02%
Pharmaceutics
2 publications, 0.68%
Phytochemistry Reviews
2 publications, 0.68%
Nature Reviews Drug Discovery
2 publications, 0.68%
Chemico-Biological Interactions
2 publications, 0.68%
Inorganic Chemistry
2 publications, 0.68%
Organic Letters
2 publications, 0.68%
Journal of Organic Chemistry
2 publications, 0.68%
Inorganic Chemistry Frontiers
2 publications, 0.68%
MedChemComm
2 publications, 0.68%
Physical Chemistry Chemical Physics
2 publications, 0.68%
Journal of Biomolecular Structure and Dynamics
2 publications, 0.68%
10
20
30
40
50
60
70
80
90

Publishers

20
40
60
80
100
120
140
American Chemical Society (ACS)
122 publications, 41.5%
Elsevier
63 publications, 21.43%
Wiley
30 publications, 10.2%
Royal Society of Chemistry (RSC)
23 publications, 7.82%
MDPI
19 publications, 6.46%
Springer Nature
13 publications, 4.42%
Taylor & Francis
8 publications, 2.72%
Georg Thieme Verlag KG
4 publications, 1.36%
Cold Spring Harbor Laboratory
2 publications, 0.68%
SAGE
1 publication, 0.34%
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.34%
American Society for Microbiology
1 publication, 0.34%
Institute of Molecular Biology and Genetics (NAS Ukraine)
1 publication, 0.34%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.34%
Water Environment Federation
1 publication, 0.34%
Pharmaceutical Society of Japan
1 publication, 0.34%
Bentham Science Publishers Ltd.
1 publication, 0.34%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.34%
20
40
60
80
100
120
140
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
294
Share
Cite this
GOST |
Cite this
GOST Copy
Johnson T. W., Gallego R. A., Edwards M. P. Lipophilic Efficiency as an Important Metric in Drug Design // Journal of Medicinal Chemistry. 2018. Vol. 61. No. 15. pp. 6401-6420.
GOST all authors (up to 50) Copy
Johnson T. W., Gallego R. A., Edwards M. P. Lipophilic Efficiency as an Important Metric in Drug Design // Journal of Medicinal Chemistry. 2018. Vol. 61. No. 15. pp. 6401-6420.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.jmedchem.8b00077
UR - https://doi.org/10.1021/acs.jmedchem.8b00077
TI - Lipophilic Efficiency as an Important Metric in Drug Design
T2 - Journal of Medicinal Chemistry
AU - Johnson, Ted W
AU - Gallego, Rebecca A
AU - Edwards, Martin P
PY - 2018
DA - 2018/03/28
PB - American Chemical Society (ACS)
SP - 6401-6420
IS - 15
VL - 61
PMID - 29589935
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2018_Johnson,
author = {Ted W Johnson and Rebecca A Gallego and Martin P Edwards},
title = {Lipophilic Efficiency as an Important Metric in Drug Design},
journal = {Journal of Medicinal Chemistry},
year = {2018},
volume = {61},
publisher = {American Chemical Society (ACS)},
month = {mar},
url = {https://doi.org/10.1021/acs.jmedchem.8b00077},
number = {15},
pages = {6401--6420},
doi = {10.1021/acs.jmedchem.8b00077}
}
MLA
Cite this
MLA Copy
Johnson, Ted W., et al. “Lipophilic Efficiency as an Important Metric in Drug Design.” Journal of Medicinal Chemistry, vol. 61, no. 15, Mar. 2018, pp. 6401-6420. https://doi.org/10.1021/acs.jmedchem.8b00077.